1. Medtronic will present at Bernstein's 41st Strategic Decisions Conference. 2. CEO Geoff Martha and CFO Thierry Piéton will discuss company strategies. 3. A live webcast will be available for investors on May 29, 2025. 4. Medtronic emphasizes its commitment to healthcare technology innovations. 5. Forward-looking statements carry inherent risks and uncertainties.
The conference presentation may showcase innovative strategies, attracting investor interest. Similar previous events have positively influenced MDT's stock price due to optimistic forward guidance.
The event highlights Medtronic's strategic direction and potential innovations, making it significant for current and prospective investors.
The upcoming conference can lead to immediate investor reactions, impacting MDT's stock in the near term. A successful Q&A session may bolster shareholder confidence quickly.
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conference on Thursday, May 29, 2025.
Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation beginning at 11:00 a.m. EDT (10:00 a.m. CDT). Immediately following the presentation, Martha will be joined by Thierry Piéton, Medtronic executive vice president and chief financial officer, to answer questions about the company.
A live webcast of the presentation and Q&A session will be available on May 29, 2025, by clicking on the Events link at http://investorrelations.medtronic.com. An archive of the presentation and Q&A session will be available on the same webpage later in the day.
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Erika Winkels
Public Relations
+1-763-526-8478
Ryan Weispfenning
Investor Relations
+1-763-505-4626
SOURCE Medtronic plc